Group 6 Copy 262
0
    Please wait...

    About This Project

    The etiological agent for Chagas' disease is the protozoan parasite Trypanosoma cruzi, which affects 6 - 7 million people primarily in Latin America. The chronic stage of infection causes cardiomyopathy and the enlargement of other organs resulting in disease burden and death. There is an urgent need to replace the clinical therapeutics (benznidazole & nifurtimox) and this proposal focuses on a compound screen to observe a hit expansion with the target T. cruzi glucokinase.

    Blast off!

    Browse Other Projects on Experiment

    Related Projects

    Finding a Cure for Mitochondrial DNA Diseases through COX2 Variations to Restore Cell Function

    Inherited and acquired mutations in the mitochondrial DNA can lead to several debilitating diseases, including...

    Can Data Management Tools Improve Research Efficiency and Reproducibility?

    Scientists are generating data at unprecedented rates, but our data management methods have yet to evolve...

    Does Antidepressant Use by Breastfeeding Mothers Lead to Autism?

    The aim of the current project is to investigate the consequences of developmental exposure to antidepressants...

    Backer Badge Funded